Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma
This study is a local, prospective, non-interventional, non-controlled, multicenter,
observational study (regulatory postmarketing surveillance). Each physician will enroll
patients who have received at least 1 dose of Yervoy, and each patient will be followed for
up to 12 months. All patients will be evaluated for safety and effectiveness during Yervoy
use (4 doses) and for 12 months from the first dose of Yervoy to confirm the safety profile
of Yervoy under routine, daily practice
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
N/A and Over
More Inclusion & Exclusion Criteria
- All patients who are initiating treatment with Yervoy
- Not Applicable
Other protocol defined inclusion/exclusion criteria could apply
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.